References
- Lawn JE, Blencowe H, Oza S, et al. Every newborn: progress, priorities, and potential beyond survival. Lancet 2014;384(9938):189-205
- Le Doare K, Heath PT. An overview of global GBS epidemiology. Vaccine 2013;31(Suppl 4):D7-12
- Conclusions from the WHO multicenter study of serious infections in young infants. The WHO young infants study group. Pediatr Infect Dis J 1999;18(Suppl 10):S32-4
- Gray KJ, Bennett SL, French N, et al. Invasive group B streptococcal infection in infants. Malawi. Emerg Infect Dis 2007;13(2):223-9
- Delair S, Mukhtar M, Olateju E, et al. Isolates from bacteremic neonates in central Nigeria - a pilot study. In: World society of pediatric infectious diseases conference, Cape Town, South Africa, 2013
- Viswanathan R, Singh AK, Basu S, et al. Multi-drug resistant gram negative bacilli causing early neonatal sepsis in India. Arch Dis Child Fetal Neonatal Ed 2012;97(3):F182-7
- Stoll BJ, Schuchat A. Maternal carriage of group B streptococci in developing countries. Pediatr Infect Dis J 1998;17(6):499-503
- Zaidi AK, Thaver D, Ali SA, Khan TA. Pathogens associated with sepsis in newborns and young infants in developing countries. Pediatr Infect Dis J 2009;28(1 Suppl):S10-18
- Dagnew AF, Cunnington MC, Dube Q, et al. Variation in reported neonatal group B streptococcal disease incidence in developing countries. Clin Infect Dis 2012;55(1):91-102
- Johri AK, Lata H, Yadav P, et al. Epidemiology of Group B Streptococcus in developing countries. Vaccine 2013;31(Suppl 4):D43-5
- Darmstadt GL, Saha SK, Choi Y, et al. Population-based incidence and etiology of community-acquired neonatal bacteremia in Mirzapur, Bangladesh: an observational study. J Infect Dis 2009;200(6):906-15
- Hamer DH, Darmstadt GL, Carlin JB, et al. Etiology of bacteremia in young infants in six countries. Pediatr Infect Dis J 2015;34(1):e1-8
- Bizzarro MJ, Dembry LM, Baltimore RS, Gallagher PG. Changing patterns in neonatal Escherichia coli sepsis and ampicillin resistance in the era of intrapartum antibiotic prophylaxis. Pediatrics 2008;121(4):689-96
- Bromiker R, Ernest N, Meir MB, et al. Correlation of bacterial type and antibiotic sensitivity with maternal antibiotic exposure in early-onset neonatal sepsis. Neonatology 2013;103(1):48-53
- Capan-Melser M, Mombo Ngoma G, Akerey-Diop D, et al. Evaluation of intermittent preventive treatment of malaria against group B Streptococcus colonization in pregnant women: a nested analysis of a randomized controlled clinical trial of sulfadoxine/pyrimethamine versus mefloquine. J Antimicrob Chemother 2015;70(6):1898-902
- Mavenyengwa RT, Moyo SR, Nordbo SA. Streptococcus agalactiae colonization and correlation with HIV-1 and HBV seroprevalence in pregnant women from Zimbabwe. Eur J Obstet Gynecol Reprod Biol 2010;150(1):34-8
- Cutland CL, Schrag SJ, Thigpen MC, et al. Increased risk for group B streptococcus sepsis in young infants exposed to HIV, Soweto, South Africa, 2004-2008(1). Emerg Infect Dis 2015;21(4):638-45
- Kim SY, Russell LB, Park J, et al. Cost-effectiveness of a potential group B streptococcal vaccine program for pregnant women in South Africa. Vaccine 2014;32(17):1954-63
- Madhi SA, Dangor Z, Heath PT, et al. Considerations for a phase-III trial to evaluate a group B Streptococcus polysaccharide-protein conjugate vaccine in pregnant women for the prevention of early- and late-onset invasive disease in young-infants. Vaccine 2013;31(Suppl 4):D52-7
- Kwatra G, Adrian PV, Shiri T, et al. Natural acquired humoral immunity against serotype-specific group B Streptococcus rectovaginal colonization acquisition in pregnant women. Clin Microbiol Infect 2015;21(6):568 e513-21